Maxine R. Rubin

Frederick National Laboratory for Cancer Research

Also affiliated with National Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer”.

PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer

Cell chemical biology(2023)10.1016/j.chembiol.2023.10.023

N/A

0.425DataRank · unranked

16 citations

Meghri Katerji, Dawid Mehlich, Sophia A. Lookingbill, Venkata R. Sabbasani, Hope Liou +9 more

Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumors

Science Signaling(2025)10.1126/scisignal.ado2857

N/A

0.345DataRank · unranked

9 citations

Meghri Katerji, Marwa M. Afifi, Katherine M. Nyswaner, Carolyn C. Woodroofe, Zoe C. Edwards +22 more

Discovery of potent and selective PROTACs for the protein kinase LZK for the treatment of head and neck cancer

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.108452

N/A

0.165DataRank · unranked

2 citations

K. Bergman, Eric Lindberg, Maxine R. Rubin, Marwa Afifi, Amy L. Funk +9 more